Advertisement
Canada markets closed

  • S&P/TSX

    21,947.41
    +124.21 (+0.57%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +449.98 (+1.18%)
     

  • CAD/USD

    0.7313
    -0.0001 (-0.02%)
     

  • CRUDE OIL

    77.99
    -0.12 (-0.15%)
     

  • Bitcoin CAD

    87,336.37
    +252.37 (+0.29%)
     

  • CMC Crypto 200

    1,330.79
    +53.81 (+4.21%)
     

  • GOLD FUTURES

    2,310.10
    +1.50 (+0.06%)
     

  • RUSSELL 2000

    2,035.72
    +19.61 (+0.97%)
     

  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     

  • NASDAQ

    16,156.33
    +315.33 (+1.99%)
     

  • VOLATILITY

    13.49
    -1.19 (-8.11%)
     

  • FTSE

    8,213.49
    +41.34 (+0.51%)
     

  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     

  • CAD/EUR

    0.6792
    -0.0025 (-0.37%)
     

DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks Equity Research
·2 min read

For the quarter ended March 2024, DexCom (DXCM) reported revenue of $921 million, up 24.2% over the same period last year. EPS came in at $0.32, compared to $0.17 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $911.2 million, representing a surprise of +1.08%. The company delivered an EPS surprise of +18.52%, with the consensus EPS estimate being $0.27.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how DexCom performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- United States: $653.20 million compared to the $650.18 million average estimate based on five analysts. The reported number represents a change of +24.2% year over year.

  • Revenue- International: $267.80 million compared to the $261.24 million average estimate based on five analysts. The reported number represents a change of +24.3% year over year.

  • Revenue- Hardware: $66.70 million versus $92.54 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -25.6% change.

  • Revenue- Sensor and other: $854.30 million versus $821.02 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +31.1% change.

View all Key Company Metrics for DexCom here>>>

Shares of DexCom have returned -1.2% over the past month versus the Zacks S&P 500 composite's -3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

DexCom, Inc. (DXCM) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research